glutathione and triple negative breast cancer CD36 enhances sensitivity of cells to palmitate-induced ferroptosis The Potential of Hormonal Therapies
The Potential of Hormonal Therapies for Treatment of Triple Negative Breast Cancer Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




